HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation.

AbstractOBJECTIVE:
Obesity is associated with monocyte-macrophage accumulation in adipose tissue. Previously, we showed that glucose-stimulated production by adipocytes of serum amyloid A (SAA), monocyte chemoattractant protein (MCP)-1, and hyaluronan (HA) facilitated monocyte accumulation. The current objective was to determine how the other major nutrient, free fatty acids (FFAs), affects these molecules and monocyte recruitment by adipocytes.
RESEARCH DESIGN AND METHODS:
Differentiated 3T3-L1, Simpson-Golabi-Behmel syndrome adipocytes, and mouse embryonic fibroblasts were exposed to various FFAs (250 micromol/l) in either 5 or 25 mmol/l (high) glucose for evaluation of SAA, MCP-1, and HA regulation in vitro.
RESULTS:
Saturated fatty acids (SFAs) such as laurate, myristate, and palmitate increased cellular triglyceride accumulation, SAA, and MCP-1 expression; generated reactive oxygen species (ROS); and increased nuclear factor (NF) kappaB translocation in both 5 and 25 mmol/l glucose. Conversely, polyunsaturated fatty acids (PUFAs) such as arachidonate, eicosapentaenate, and docosahexaenate (DHA) decreased these events. Gene expression could be dissociated from triglyceride accumulation. Although excess glucose increased HA content, SFAs, oleate, and linoleate did not. Antioxidant treatment repressed glucose- and palmitate-stimulated ROS generation and NFkappaB translocation and decreased SAA and MCP-1 expression and monocyte chemotaxis. Silencing toll-like receptor-4 (TLR4) markedly reduced SAA and MCP-1 expression in response to palmitate but not glucose. DHA suppressed NFkappaB translocation stimulated by both excess glucose and palmitate via a peroxisome prolifterator-activated receptor (PPAR) gamma-dependent pathway.
CONCLUSIONS:
Excess glucose and SFAs regulate chemotactic factor expression by a mechanism that involves ROS generation, NFkappaB, and PPARgamma, and which is repressed by PUFAs. Certain SFAs, but not excess glucose, trigger chemotactic factor expression via a TLR4-dependent pathway.
AuthorsChang Yeop Han, Atil Y Kargi, Mohamed Omer, Christina K Chan, Martin Wabitsch, Kevin D O'Brien, Thomas N Wight, Alan Chait
JournalDiabetes (Diabetes) Vol. 59 Issue 2 Pg. 386-96 (Feb 2010) ISSN: 1939-327X [Electronic] United States
PMID19934003 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Acids
  • Fatty Acids, Unsaturated
  • RNA, Messenger
  • Reactive Oxygen Species
  • Saa3 protein, mouse
  • Serum Amyloid A Protein
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
Topics
  • 3T3 Cells (cytology, drug effects, physiology)
  • Adipocytes (drug effects, pathology, physiology)
  • Adipose Tissue (cytology, drug effects, physiology, physiopathology)
  • Animals
  • Cell Adhesion (physiology)
  • Cell Differentiation
  • Chemotaxis (physiology)
  • Embryo, Mammalian (cytology, physiology)
  • Fatty Acids (pharmacology)
  • Fatty Acids, Unsaturated (pharmacology)
  • Flow Cytometry
  • Gene Silencing
  • Humans
  • Hypertrophy
  • Inflammation (physiopathology)
  • Mice
  • Mice, Inbred C57BL
  • Monocytes (drug effects, physiology)
  • RNA, Messenger (genetics)
  • Reactive Oxygen Species (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Serum Amyloid A Protein (genetics)
  • Toll-Like Receptor 4 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: